Sensyne Health (LON:SENS) Stock Price Down 33.3% – Here’s Why

Sensyne Health PLC (LON:SENS)’s stock price traded down 33.3% on Friday . The stock traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). 4,449,142 shares were traded during trading, an increase of 29% from the average session volume of 3,449,819 shares. The stock had previously closed at GBX 0.53 ($0.01).

Sensyne Health Trading Down 33.3 %

The stock has a market cap of £582,624.00 and a PE ratio of -0.02. The firm has a 50-day moving average price of GBX 0.35 and a 200-day moving average price of GBX 0.35. The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.26 and a current ratio of 2.26.

Sensyne Health Company Profile

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.